Skip to main content

Thermo Fisher Scientific Value Stock - Dividend - Research Selection

Thermo fisher scientific

ISIN: US8835561023 , WKN: 857209

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, ultralow-temperature freezers and cryopreservation storage tanks, temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market

2025-04-01
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 23, 2025

2025-04-01
WALTHAM, Mass., April 01, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2025 before the market opens on Wednesday, April 23, 2025, and will hold a conference call on the same day at 8:30 a.m. ET.

Impax Global Social Leaders Fund Q4 2024 Commentary

2025-04-01
Impax Global Social Leaders Fund underperformed the benchmark during the quarter. Positive performance came from Industrials. Read more here.

Thermo Fisher Scientific (NYSE:TMO) Launches Sustainable Centrifuge Line Amid 4% Share Dip

2025-03-31
Thermo Fisher Scientific (NYSE:TMO) announced the launch of new floor-model centrifuges featuring sustainable technologies, marking a commitment to innovation and environmental responsibility. Despite this positive development, the company experienced a 3.8% decline in share price over the past week. This drop coincided with a broader market downturn, where major indices like the S&P 500 and Nasdaq saw significant losses due to renewed tariff concerns. The market's overall decline of 3.5%...

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate

2025-03-31
Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.

Is Thermo Fisher Scientific (TMO) The Most Expensive Stock Insiders Are Dumping In March?

2025-03-28
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader […]

Thermo Fisher Scientific Inc. stock falls Friday, underperforms market

2025-03-28
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market

Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock

2025-03-28
TMO and CZ Imaging Institute to collaborate on further understanding of human cells.

Putnam U.S. Large Cap Value Equity Concentrated SMA Q4 2024 Commentary

2025-03-27
In a challenging quarter for value stocks, the portfolio posted a negative return (-1.70% gross of fees and -2.43% net of fees), slightly outperforming Russell 1000 Value Index.

ClearBridge Large Cap Value Fund Q4 2024 Commentary

2025-03-27
Our quality bias in materials and utilities stood out the most in a quarter that saw a reversal of some of 2024’s themes.